Marshall Wace North America’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.85M Sell
13,003
-421,333
-97% -$160M 0.02% 523
2021
Q2
$166M Sell
434,336
-341,135
-44% -$130M 0.7% 21
2021
Q1
$278M Sell
775,471
-72,377
-9% -$23.3M 1.16% 9
2020
Q4
$272M Buy
847,848
+613,872
+262% +$188M 1.23% 9
2020
Q3
$62.8M Buy
233,976
+83,708
+56% +$22.5M 0.4% 55
2020
Q2
$39.5M Buy
150,268
+141,142
+1,547% +$37.7M 0.26% 98
2020
Q1
$2.07M Buy
9,126
+5,196
+132% +$1.42M 0.02% 473
2019
Q4
$1.19M Buy
3,930
+2,462
+168% +$678K 0.01% 687
2019
Q3
$353K Sell
1,468
-16,304
-92% -$4.47M ﹤0.01% 865
2019
Q2
$5.01M Sell
17,772
-353,403
-95% -$96.5M 0.03% 361
2019
Q1
$107M Buy
371,175
+347,887
+1,494% +$101M 0.76% 29
2018
Q4
$6.12M Sell
23,288
-1,474
-6% -$405K 0.06% 221
2018
Q3
$6.79M Buy
24,762
+15,253
+160% +$3.96M 0.05% 264
2018
Q2
$2.26M Sell
9,509
-288
-3% -$66.7K 0.01% 736
2018
Q1
$2.15M Buy
9,797
+2,855
+41% +$671K 0.01% 797
2017
Q4
$1.56M Sell
6,942
-35,475
-84% -$7.56M 0.01% 900
2017
Q3
$8.06M Buy
42,417
+37,761
+811% +$7.19M 0.05% 424
2017
Q2
$875K Buy
+4,656
New +$837K 0.01% 967

Other funds holding ELV